BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25075255)

  • 1. Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis.
    Ahmad A; Sethi S; Chen W; Ali-Fehmi R; Mittal S; Sarkar FH
    Am J Transl Res; 2014; 6(4):384-90. PubMed ID: 25075255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-20b is up-regulated in brain metastases from primary breast cancers.
    Ahmad A; Ginnebaugh KR; Sethi S; Chen W; Ali R; Mittal S; Sarkar FH
    Oncotarget; 2015 May; 6(14):12188-95. PubMed ID: 25893380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis.
    Liu Y; Zhao J; Zhang PY; Zhang Y; Sun SY; Yu SY; Xi QS
    Med Sci Monit; 2012 Aug; 18(8):BR299-308. PubMed ID: 22847191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-10b expression in node-negative breast cancer-correlation with metastasis and angiogenesis.
    Liu X; Guan Y; Wang L; Niu Y
    Oncol Lett; 2017 Nov; 14(5):5845-5852. PubMed ID: 29113216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.
    Parrella P; Barbano R; Pasculli B; Fontana A; Copetti M; Valori VM; Poeta ML; Perrone G; Righi D; Castelvetere M; Coco M; Balsamo T; Morritti M; Pellegrini F; Onetti-Muda A; Maiello E; Murgo R; Fazio VM
    Mol Cancer; 2014 Jun; 13():142. PubMed ID: 24897960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model.
    Ma L; Reinhardt F; Pan E; Soutschek J; Bhat B; Marcusson EG; Teruya-Feldstein J; Bell GW; Weinberg RA
    Nat Biotechnol; 2010 Apr; 28(4):341-7. PubMed ID: 20351690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up.
    Markou A; Yousef GM; Stathopoulos E; Georgoulias V; Lianidou E
    Clin Chem; 2014 Jan; 60(1):197-205. PubMed ID: 24132943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
    Nakata K; Ohuchida K; Mizumoto K; Kayashima T; Ikenaga N; Sakai H; Lin C; Fujita H; Otsuka T; Aishima S; Nagai E; Oda Y; Tanaka M
    Surgery; 2011 Nov; 150(5):916-22. PubMed ID: 22018284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA 10b promotes abnormal expression of the proto-oncogene c-Jun in metastatic breast cancer cells.
    Knirsh R; Ben-Dror I; Modai S; Shomron N; Vardimon L
    Oncotarget; 2016 Sep; 7(37):59932-59944. PubMed ID: 27494896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
    Ma L; Teruya-Feldstein J; Weinberg RA
    Nature; 2007 Oct; 449(7163):682-8. PubMed ID: 17898713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
    Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
    J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.
    Chen W; Cai F; Zhang B; Barekati Z; Zhong XY
    Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
    EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma.
    Jikuzono T; Kawamoto M; Yoshitake H; Kikuchi K; Akasu H; Ishikawa H; Hirokawa M; Miyauchi A; Tsuchiya S; Shimizu K; Takizawa T
    Int J Oncol; 2013 Jun; 42(6):1858-68. PubMed ID: 23563786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-10b expression predicts long-term survival in patients with solid tumor.
    Zhang Y; Wang LJ; Yang HQ; Wang R; Wu HJ
    J Cell Physiol; 2019 Feb; 234(2):1248-1256. PubMed ID: 30191959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials.
    Savan NA; Saavedra PV; Halim A; Yuzbasiyan-Gurkan V; Wang P; Yoo B; Kiupel M; Sempere L; Medarova Z; Moore A
    Front Oncol; 2022; 12():959630. PubMed ID: 36387245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4.
    Ahmad A; Ginnebaugh KR; Yin S; Bollig-Fischer A; Reddy KB; Sarkar FH
    BMC Cancer; 2015 Jul; 15():540. PubMed ID: 26206152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.
    Kim J; Siverly AN; Chen D; Wang M; Yuan Y; Wang Y; Lee H; Zhang J; Muller WJ; Liang H; Gan B; Yang X; Sun Y; You MJ; Ma L
    Cancer Res; 2016 Nov; 76(21):6424-6435. PubMed ID: 27569213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.